Newsroom

Device Developed at MIT Helps Determine Targeted Drug Treatment

With precision medicine an accepted paradigm in cancer treatment, finding the right targeted drug treatment for each patient can prove challenging. MIT chemical engineers have designed an implantable device, which is about the size [...]

By |2019-04-08T10:26:15-04:00May 20th, 2015|News, Research|

International Seminar on Cancer Policies in South America

In Santiago, Chile, on April 22, 2015, The Chilean Health Ministry (MINSAL) organized a seminar to discuss regional policies for cancer prevention and control. Representatives of WHO, OPS, RINC, and UNASUR, were invited along [...]

By |2019-04-08T10:24:18-04:00May 7th, 2015|Advocacy, News|

Importance of Therapeutic Drug Monitoring for Targeted Therapies

As personalized medicine has become an accepted paradigm, it may be time for oncologists to examine personalized dose levels.In a recent article from Cancer World, the author explores the value of therapeutic drug monitoring for [...]

By |2019-04-08T10:18:30-04:00May 1st, 2015|Drug Treatment, News|

Blueprint Medicines Presents Preclinical Data on BLU-285

Blueprint Medicines presented new preclinical data on its drug candidate, BLU-285, and its potential value in  treatment-resistant GIST and on novel cancer drug targets at the AACR (American Association for Cancer Research) Annual Meeting [...]

By |2019-04-08T10:13:47-04:00April 24th, 2015|D842V, News, Research|
Go to Top